Cargando…
Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma
Lung adenocarcinoma is one of the most common cancers worldwide. However, the molecular mechanisms of lung adenocarcinoma development are still unclear. This study aimed to investigate the expression profiles of anti-lung cancer target genes in different cancer stages and to explore their functions...
Autores principales: | Liu, Hong-Yan, Zhao, Hui, Li, Wen-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373997/ https://www.ncbi.nlm.nih.gov/pubmed/30803369 http://dx.doi.org/10.1177/1533033819827317 |
Ejemplares similares
-
Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma
por: Bai, Kaisong, et al.
Publicado: (2021) -
Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017) -
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
por: Stewart, Paul A., et al.
Publicado: (2015) -
Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma
por: Yin, Yi, et al.
Publicado: (2023) -
Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer
por: Xu, Can, et al.
Publicado: (2022)